cell line-derived neurotrophic factor promotes barrier maturation and wound healing in intestinal epithelial cells in vitro. Recent data suggest that neurotrophic factors from the enteric nervous system are involved in intestinal epithelial barrier regulation. In this context the glial cell line-derived neurotrophic factor (GDNF) was shown to affect gut barrier properties in vivo directly or indirectly by largely undefined processes in a model of inflammatory bowel disease (IBD). We further investigated the potential role and mechanisms of GDNF in the regulation of intestinal barrier functions. Immunostaining of human gut specimen showed positive GDNF staining in enteric neuronal plexus and in enterocytes. In Western blots of the intestinal epithelial cell lines Caco2 and HT29B6, significant amounts of GDNF were detected, suggesting that enterocytes represent an additional source of GDNF. Application of recombinant GDNF on Caco2 and HT29B6 cells for 24 h resulted in significant epithelial barrier stabilization in monolayers with immature barrier functions. Wound-healing assays showed a significantly faster closure of the wounded areas after GDNF application. GDNF augmented cAMP levels and led to significant inactivation of p38 MAPK in immature cells. Activation of p38 MAPK signaling by SB-202190 mimicked GDNF-induced barrier maturation, whereas the p38 MAPK activator anisomycin blocked GDNF-induced effects. Increasing cAMP levels had adverse effects on barrier maturation, as revealed by permeability measurements. However, increased cAMP augmented the proliferation rate in Caco2 cells, and GDNF-induced proliferation of epithelial cells was abrogated by the PKA inhibitor H89. Our data show that enterocytes represent an additional source of GDNF synthesis. GDNF contributes to wound healing in a cAMP/PKA-dependent manner and promotes barrier maturation in immature enterocytes cells by inactivation of p38 MAPK signaling.
GDNF; intestinal barrier; p38 MAPK; barrier maturation; wound healing THE INTEGRITY of intestinal epithelial barrier functions is deranged under several pathophysiological conditions, such as severe systemic inflammation and inflammatory bowel diseases (38) . The intestinal epithelial barrier is formed by a monolayer of enterocytes that are held together and sealed by circumferential intercellular junctions. The integrity of the intestinal epithelial barrier is dependent on mature tight and adherens junctions that form the terminal bar (10) . Addition-ally, there is a permanent turnover of differentiating cells that migrate and maturate from proliferative crypt (stem) cells to the apical villi of the gut, which provides the formation of a tight and selective gut barrier (16) . In general, it is assumed that intestinal villi with a mature barrier have a huge number of narrow tight junctions, whereas junctions in the crypts are more leaky (15) . Therefore,it is important to investigate enterocyte function at different stages of differentiation.
It is well known that the enteric nervous system (ENS) plays an important role in the regulation of intestinal epithelial barrier function (23) . In support of that, it was recently shown that gut microbiota influences the ENS, which in turn affects epithelial integrity (17) . The ENS is represented by a neuronal/ glial network that is located in the gastrointestinal wall and is composed of the myenteric and the submucosal plexus. It consists of two major cell populations: enteric neurons and enteric glial cells. It has been shown that neuronal effector proteins such as acetylcholine, vasoactive intestinal peptide (VIP), and nitric oxide (NO) are key regulators of intestinal barrier functions since they influence mucosal blood flow, lymphocyte migration, mucus secretion, and resorption of nutrients (14, 22) . Although there is much information regarding the influence of neuronal effectors, little is known about the effector proteins secreted by the accompanying glial cells.
Yet there is upcoming evidence that the enteric glial cells or factors secreted by these cells play an important role in the regulation of intestinal barrier function. First, it has been shown that a toxic or autoimmune ablation of some enteric glial cells leads to a breakdown of intestinal barrier function in mice (5, 8) . Second, there is a reduced distribution of enteric glial cells in healthy colon segments of patients suffering from inflammatory bowel disease compared with control populations, indicating that enteric glial cells could play a role in the pathogenesis of Crohn's disease or ulcerative colitis (40) .
The main mediator secreted by enteric glial cells is the glial cell line-derived neurotrophic factor (GDNF), which has effects on proliferation on glial cells and neurons in the embryonic development of the enteric nervous system (43) . Moreover, it has been consistently reported that reduced levels of GDNF lead to morphological and functional abnormalities of intestinal barrier function in mice similar to inflammatory bowel diseases (4, 41, 45) . This was explained by the observation that neurotrophins have anti-inflammatory effects and GDNF exerts antiapoptotic effects on colonic epithelial cells (25, 36) . Additionally, recent data from endothelial cells suggest that GDNF has a direct effect on junctional proteins of the blood-brain barrier, where GDNF led to increased endothelial barrier function by upregulation of the tight-junction protein claudin-5 (34, 42) .
Based on these observations, we hypothesized that GDNF may have direct effects on the intestinal epithelium and intercellular junctions, which may contribute directly to the regulation of epithelial barrier properties. Therefore, we investigated the effects of GDNF on intestinal epithelial barrier functions in an in vitro cell culture model of the intestinal barrier under conditions of mature and immature monolayers.
MATERIALS AND METHODS
Human tissue samples. Human tissue samples (n ϭ 3) derived from the terminal ileum of patients who required right hemicolectomy due to colon carcinoma, in which the surgical resection involves a part of the healthy terminal ileum. All patients had given their informed consent prior to surgery, and approval was given by the ethics board of the University of Wuerzburg (proposal no. 113/13). Samples where snap-frozen in liquid nitrogen immediately after resection and then analyzed as described below.
Cell culture. HT29B6 cells were provided by Joerg-Dieter Schulzke (Department of Clinical Physiology, Charité Campus Benjamin Franklin, Berlin, Germany) and cultured in RPMI Medium 1640 (Ginco, Darmstadt, Germany), as described previously (18) . Caco2 cells were acquired from ATCC (Wesel, Germany) and were cultured in Dulbecco's modified Eagles medium (DMEM; Life Technologies, Karlsruhe, Germany). Both media were supplemented with 50 U/ml penicillin-G, 50 g of streptomycin and 10% fetal calf serum (FCS; Biochrom, Berlin, Germany), and the two cell lines were cultured in a humidified atmosphere (95% air-5% CO 2) at 37°C. Cultures were used for experiments when grown to confluent monolayers or as indicated below. For experiments, cells were serum-starved for 24 h.
Test reagents. Caco2 and HT29B6 monolayers were treated with recombinant human GDNF (PeproTech). Preliminary dose-response experiments confirmed that GDNF at a dose of 100 ng/ml in Caco2 and of 200 ng/ml in HT29B6 cells was effective to mediate effects in both cell lines, as described previously for the endothelial barrier (34) . To block activation of protein kinase A (PKA) the inhibitor H89 (Calbiochem, Darmstadt, Germany) at 30 M was used. We mimicked inflammation-induced breakdown of the intestinal barrier with cytomix: 10 ng/ml TNF␣ (Biomol, Hamburg, Germany), 10 g/ml IL-1␤ (Sigma, St. Louis, MO), and 0.05 g/ml interferon-␥ (Millipore, Darmstadt, Germany), as reported previously (6) . SB-202190 (Callbiochem) was used at 30 M to inhibit p38 mitogen-activated protein kinase (p38 MAPK). Anisomycin (Sigma-Aldrich, Munich, Germany) was used at 60 mol/l to activate p38 MAPK. Forskolin (Sigma Aldrich, St. Louis, MO) at 5 M and rolipram (Sigma Aldrich, St. Louis, MO) at 10 M were used to increase intracellular levels of cAMP.
Immunocytochemistry. Human tissue samples were fixed in 4% paraformaldehyde, embedded in paraffin, and sectioned (1 m). Immunostaining was performed after removal of paraffin, as described previously (35) . Cultured cell monolayers were prepared for immunostaining, as described before (29) . In brief, epithelial cells were grown to confluence on coverslips, as indicated below. After incubation with or without different mediators as indicated below, cells were fixated with 2% formaldehyde for 10 min at room temperature. After treatment with 0.1% Triton X-100 for 15 min, monolayers were incubated at 4°C overnight using the following primary antibodies (1:100 each in PBS): mouse anti-E-cadherin (BD Transduction Laboratories), mouse anti-occludin (Invitrogen), mouse anti-Ki-67 (Dako, Glostrup, Denmark), mouse anti-claudin-5 antibody (Invitrogen, Darmstadt, Germany), rabbit anti-claudin-1 (Invitrogen), mouse anti-S100-␤ (Abcam, Cambridge, UK), and goat anti-GDNF (R & D Systems, Abingdon, UK). As secondary antibodies we used Cy3labeled goat anti-mouse, goat anti-rabbit, or mouse anti-goat (diluted 1:600 in PBS; all from Dianova, Hamburg, Germany). Coverslips were mounted on glass slides with Vector Shield Mounting Medium as anti-fading compound, which additionally included DAPI to counterstain cell nuclei (Vector Laboratories, Burlingham, CA). Representative experiments were photographed with a fluorescence microscope BZ-9000 (BIOREVO; Keyence, Osaka, Japan).
cAMP activation assay. For quantification of intracellular cyclic adenosine monophosphate (cAMP) levels, the commercial format cAMP "plus" enzyme immunoassay (Biomol, Hamburg, Germany) was used according to manufacturer's recommendations, as described previously (2) . Concentrations of cAMP in pmol/ml of each control experiment were set to 100% and compared with cAMP levels of cell lysates treated as indicated below.
Western blotting. For Western blot analysis, human tissue samples were lysed and homogenized in SDS lysis buffer containing 25 mmol/l HEPES, 2 mmol/l EDTA, 25 mmol/l NaF, and 1% sodium dodecyl sulfate. Cultured cells were grown in 24-well plates and lysed using SDS lysis buffer.
SDS gel electrophoresis and immunoblotting were carried out as described previously (16) . Antibodies against pp38 MAPK and p38 MAPK (Cell Signaling Technology, Cambridge, UK) and antibodies against GDNF receptor (GFR)␣1, GFR␣2, rearranged during transfection receptor (RET) (Abcam, Cambridge, UK), and anti-GDNF (R & D Systems, Abingdon, UK) were used at a dilution of 1:500. As secondary antibodies, the respective horseradish peroxidase-labeled goat anti-rabbit IgG, goat anti-mouse, and goat anti-rat IgG (Santa Cruz Biotechnology, Heidelberg, Germany) were used (1:3,000 in PBS). Chemiluminescence signal detection and quantification were performed by densitometry (FluorChem FC2 Imaging Systems, Multiimage II; Alpha Innotech, Santa Clara, CA).
Measurement of transepithelial resistance. ECIS 1600R (Applied BioPhysics) was used to measure transepithelial resistance (TER) of epithelial monolayers to assess epithelial barrier functions, as described previously for HT29B6 and for Caco2 cells (26, 30) . Twohundred microliters of epithelial cell suspension was seeded in the wells of the electrode array. Baseline TER was measured for 10 min to equilibrate monolayers. Afterwards, 200 l of medium containing different mediators or medium without mediators was applied to the wells.
Measurement of FITC-dextran flux across monolayers of cultured epithelial cells. As described previously (28) , epithelial cells were seeded on top of transwell chambers on six-well plates (0.4-m pore size; Falcon, Heidelberg, Germany) and grown to confluence. After rinsing with PBS, cells were incubated with fresh DMEM without phenol red (Sigma) containing 10 mg/ml FITC-dextran (4 kDa) in the presence or absence of different mediators, as indicated below. Paracellular flux was assessed by taking 100-l aliquots from the outer chamber over 2 h of incubation. Fluorescence was measured using a Wallac Victor 2 fluorescence spectrophotometer (Perkin-Elmer, Ü berlingen, Germany) with excitation and emission at 485 and 535 nm, respectively. For all experimental conditions, permeability coefficients (P E) were calculated by the following formula ( Wound-healing assay. Wound-healing (scratch) assays were performed on six-well petri dishes to measure cell migration and cell proliferation in vitro (20) . A standardized scratch was applied on a Caco2 monolayer using the tip of a 100-l pipette. Immediately after the scratch medium was changed, scratch areas were photographed using a BZ-9000 (BIOREVO) microscope (Keyence, Osaka, Japan). The scratch was performed blinded by same investigator in the same way so that wounded areas had approximately similar sizes in all experiments to minimize any possible variations caused by the difference in the width of the scratches. Afterwards, cells were treated with or without different mediators, as indicated below. The wounded areas were photographed after 24, 48, and 72 h. Wound closure was determined by the ratio of wounded area compared with the initial scratch area using ImageJ Software (Wayne Rasband; National Institutes of Health) by a second independent investigator.
Evaluation of cell proliferation. To evaluate to the amount of proliferating cells, immature Caco2 monolayers were stained with DAPI (Calbiochem) to visualize cell nuclei, and immunostaining for Ki-67 was performed as described above for the different conditions. Ki-67 is well known to be strictly associated with cell proliferation, and therefore, it provides a suitable marker for cell proliferation (32) . Three randomly chosen high-power fields per experiment were then analyzed in a investigator-blinded investigation for the total number of cells, as indicated by the total number of cell nuclei per area and the number of Ki-67-positive stained cells to determine proliferating cells. The ratio served to demonstrate the relative amount of proliferating cells under the different conditions.
Statistics. Statistical analysis was performed using Prism (Graph-Pad Software, La Jolla, CA). Data are presented as means Ϯ SE. Statistical significance was assumed for P Ͻ 0.05. Paired Student's t-test was performed for two-sample group analysis after checking for a Gaussian distribution. Analysis of variance followed by Bonferroni correction was used for multiple sample groups.
RESULTS

Enterocytes represent a source of GDNF and express GDNF receptors.
To evaluate the sources of GDNF in the human intestine, we used samples of the healthy terminal ileum of patients who required right hemicolectomy due to a colon carcinoma. Right hemicolectomy requires us to resect a part of the terminal ileum that enabled the analysis of healthy intestinal tissue. As expected, immunostaining of the tissue sections from the terminal ileum with GDNF and the glial cell marker S100 revealed a colocalization of S100 and GDNF in the submucosal plexus and the myenteric plexus (Fig. 1A , image c). Additionally, we constantly found a positive staining pattern for GDNF in enterocytes ( Fig. 1A , images e and h). To verify this observation, we dissected the mucosa from the specimen for Western blot analysis. In the lysates of the mucosa we found a positive Western blot band for GDNF and the enterocyte marker Villin, whereas the glial cell marker S100 was not detected (Fig. 1B) . In whole tissue lysates, Western blot bands for S100, GDNF, and Villin were found (Fig. 1B) . The latter observations led to the hypothesis that enterocytes may represent an additional source for GDNF synthesis. However, since the GDNF signal in enterocytes from gut specimen may represent bound GDNF that had previously been secreted by the neuronal plexus, we tested whether cultured intestinal epithelial cells contain GDNF. Cell lysates were analyzed by Western blotting with and without serum starvation. Both Caco2 and HT29B6 cells showed a strong band for GDNF, suggesting that enterocytes synthesize significant amounts of GNDF (Fig. 1C ). Moreover, GDNF was also found in supernatants of serum-starved Caco2 cells (not shown).
Next, we tested whether the Caco2 and HT29B6 cell lines express GDNF-susceptible receptors GFR␣1, GFR␣2, and RET at different stages of differentiation, i.e., on the day before monolayer confluence (C Ϫ1), on the day of confluence (C0), and 1 day after confluence (C ϩ1), when cells showed a stable and differentiated monolayer (also see below). As revealed by Western blotting, GFR␣1, GFR␣2, and RET receptors were equally present in both cell lines at the different stages from C Ϫ1 to C ϩ1 in Caco2 cells (Fig. 1, D and F) and HT29B6 (Fig. 1E ).
GDNF did not affect epithelial barrier properties under conditions of mature intercellular junctions. To evaluate whether GDNF exerts direct effects on intestinal epithelium, we used the previously established and characterized Caco2 in vitro transwell model (29) . We performed immunostaining and permeability measurements (P E ) of 4-kDa FITC-dextran flux across mature Caco2 monolayers with and without application of GDNF at different concentrations. As established previously, mature barrier functions were assumed when P E values ranged ϳ2.0 -2.5 cm/s ϫ 10 Ϫ7 , and cell junctions at the cell borders showed linear staining patterns (29) . Additionally, we used HT29B6 cells, which represent a cell line that derived from a differentiated subclone of the HT29 cell line and has previously been shown to be suitable for studies on intestinal epithelial barrier functions (18) . According to baseline experiments, we assumed mature barrier conditions in HT29B6 cells when P E values ranged from 1.7 to 2.2 cm/s ϫ 10 Ϫ6 and when cell junctions showed linear staining patterns. This was the case in both cell lines when experiments started 1 day after confluence of the monolayers (C ϩ1).
Because it must be assumed that differentiated epithelial barrier functions resemble conditions seen predominantly in the apical part of the villi, we additionally tested the effects of GDNF under conditions of immature barrier functions, a condition that is supposed to be found in crypts. Therefore, we defined immature barrier conditions of monolayers, when P E exceeded more than two standard deviations from conditions in mature monolayers. This was the case in both cell lines when experiments started 1 day before confluence (C Ϫ1).
In measurements of TER, application of GDNF on immature Caco2 monolayers resulted in significantly increased TER values beginning 8 h after application of GDNF ( Fig. 2A) . In contrast, application of GDNF on mature Caco2 monolayers had no effects on TER (Fig. 2B ).
In measurements of 4-kDa FITC-dextran flux, baseline P E of immature Caco2 was 4.13 Ϯ 0.38 cm/s ϫ 10 Ϫ7 under control conditions. This was significantly decreased following application of GDNF for 24 h, when P E was 2.99 Ϯ 0.26 cm/s ϫ 10 Ϫ7 (Fig. 2C ). In mature Caco2 monolayers, P E was 1.73 Ϯ 0.27 cm/s ϫ 10 Ϫ7 in controls, which was unchanged after incubation with GDNF for 24 h (Fig. 2C ). Comparable results were obtained in permeability measurements using immature HT29B6, where GDNF application led to a 20% reduction of P E from 2.68 Ϯ 0.18 cm/s ϫ 10 Ϫ6 after GDNF treatment to 3.39 Ϯ 0.32 cm/s ϫ 10 Ϫ6 in immature control monolayers. No effects of GDNF on monolayer permeability were observed in mature HT29B6 cells (P E 1.94 Ϯ 0.14 cm/s ϫ 10 Ϫ6 in controls vs. 2.05 Ϯ 0.14 cm/s ϫ 10 Ϫ6 after application of GDNF for 24 h; Fig. 2D ).
To test whether application of GDNF is effective to block inflammation-induced breakdown of the epithelial barrier, we mimicked inflammation-induced breakdown of intestinal barrier functions by incubation of monolayers with "cytomix," a combination of proinflammatory cytokines TNF␣, interleukin-1␤, and interferon-␥ (6) . Incubation with cytomix led to a significant increase of P E in Caco2 cells to 3.33 Ϯ 0.25 cm/s ϫ 10 Ϫ7 . However, incubation of GDNF together with cytomix did not block intestinal epithelial barrier function in our in vitro model since under these conditions P E was 3.18 Ϯ 0.67 cm/s ϫ 10 Ϫ7 (Fig. 2E ). Fig. 1 . Enterocytes are a source of glial cell line-derived neurotrophic factor (GDNF). A: immunostaining of human tissue sections of the terminal ileum for glial cell marker S100 and GDNF was performed (images a-i). Arrows in images a and c point to the submucosal plexus, arrows in images e and f examplify enterocytes positively stained for GDNF, and the arrow in image g points to the myenteric plexus. Application of secondary antibodies without primary antibody served as negative controls to exclude staining artefacts (images k-m). In images a-c, overview images at 4-fold magnification show positive immunostaining for GDNF at the level of the mucosa and the submucosa, which is shown in more detail in villi (images d-f) and in crypts (images g-i). This was not observed in the negative controls (images k-m) (n ϭ 3; scale bars in images a-c: ϫ4 ϭ 200 m; all other scale bars: ϫ63 ϭ 20 m). B: in Western blots, positive bands for GDNF in lysates of the mucosa and lysates of full wall gut specimen were found. Recombinant GDNF (rGDNF; lane 1) served as positive control. Membranes were reprobed for villin, which was present in full wall lysates and in mucosa lysates. The glial cell marker S100 was present only in full wall lysates and not in mucosa lysates, demonstrating successful mucosa dissection (Western blot shown is representative for n ϭ 3). C: Caco2 cells and HT29B6 cell lysates were positive for GDNF with (ϪFCS) and without serum starvation (ϩFCS). Membranes were reprobed with ␤-actin to test for equal protein loading. Application of rGDNF (lane 1) served as positive control (Western blots shown are representative for n ϭ 6). D and E: GDNF receptor (GFR) expression RET (rearranged during transfection receptor), GFR␣1, and GFR␣2 are shown in Western blots for Caco2 (D) and HT29B6 (E) at different stages of differentiation (C Ϫ1, C0, and C ϩ1). GAPDH served as loading control (Western blots shown are representative for n ϭ 6). F: measurement of optical density of Western blots demonstrated no significant changes in protein concentrations of GFR during differentiation in Caco2 cells.
To assess changes on junctional morphology following incubation with GDNF, we performed immunostaining for adherens junctions protein E-cadherin and for tight-junction proteins claudin-1, claudin-5, and occludin under the different experimental conditions. In immunostaining of immature Caco2 monolayers, E-cadherin was regularly distributed at the cell borders, whereas tight-junction proteins claudin-1, claudin-5, and occludin were overall reduced at the cell borders ( Fig. 3A images b-d ) compared with monolayers with mature barrier properties (Fig. 3A, images i-m) . Application of GDNF on immature Caco2 cells for 24 h led to augmented and regular staining patterns at the cell borders of both tight and adherens junctions proteins ( Figs. 2C and 3A , images e-h). As outlined above, in mature Caco2 monolayers adherens junction protein E-cadherin (Fig. 3A, image i) and tight-junction proteins claudin-5, claudin-1, and occludin (Fig. 3A, images l, m, and n) were regularly distributed at the cell borders under control conditions. No changes in immunostaining for E-cadherin and tight junction proteins were observed after incubation with GDNF for 24 h (Fig. 3A, images o-r) . Comparable results were obtained in immunostaining of immature HT29B6 monolayers; E-cadherin staining was largely unchanged following incubation with GDNF, and tight-junction proteins occludin and claudin-1 showed augmented and more linear staining patterns at the cell borders (Fig. 3B, images a-h) . No changes were observed in immunostaining for E-cadherin, claudin-1, claudin-5, and occludin when GDNF-treated monolayers and untreated monolayers were compared in mature HT29B6 monolayers. In Western blot analysis, concentrations of junctional proteins were not altered after incubation with GDNF for 24 h in either immature or mature Caco2 or HT29B6 cells (Fig. 3,  C and D) .
In summary, these experiments demonstrated that GDNF promotes maturation of intercellular junctions in Caco2 and HT29B6 monolayers but does not affect mature barrier functions.
GDNF mediates barrier maturation via inactivation of p38 MAPK. Because GDNF was shown to affect both cAMPdependent signaling pathways as well as p38 MAPK signaling in other cell types (19) , we tested whether cAMP levels and/or p38MAPK were altered in immature Caco2 cells following GDNF application. Indeed, we found that GDNF significantly raised cAMP levels to 122 Ϯ 8% of controls, as revealed by ELISA-based measurements in immature Caco2 cells (Fig. 4A ) but not in mature Caco2 cells (data not shown). Phosphorylation of p38 MAPK was significantly reduced following GDNF application for 24 h in immature Caco2 cells (Fig. 4, C and D) , which was not observed in mature Caco2 cells (data not shown).
To test whether increased cAMP levels or inhibition of p38 MAPK would account for maturation of barrier properties, we augmented cAMP levels in immature Caco2 using adenylylcyclase activator forskolin together with phosphodiesterase-4 inhibitor rolipram (F/R). Application of F/R even had adverse effects on epithelial barrier properties and led to significantly increased permeability in immature Caco2 cells (Fig. 4B ). Inhibition of PKA using H-89 did not alter P E compared with controls. However, H-89 blocked barrier-stabilizing effects of GDNF (Fig. 4B) . In a comparable attempt, p38 MAPK signaling was blocked in immature Caco2 cells by application of SB-202190 for 24 h (Fig.  4E ). Under these conditions, barrier properties were significantly improved. Consistently, activation of p38 MAPK by anisomycin led to a significant increase in P E . Application of anisomycin blocked GDNF-mediated barrier stabilization in Caco2 monolayers. Similar results were obtained in immature HT29B6 monolayers, where anisomycin blocked the barrier-maturating effect of GDNF (Fig. 4F) .
In summary, these data suggested inactivation of p38 MAPK by GDNF to be the predominant mechanism for epithelial barrier stabilization, whereas augmented cAMP levels had negative effects on epithelial barrier maturation. Fig. 3 . GDNF led to augmented and more linear staining patterns in tight junctions under immature barrier conditions. A and B: immunostaining was performed in Caco2 cells (A) and HT29B monolayers (B). Application of GDNF for 24 h in immature barrier conditions led to a slight change in E-cadherin staining in Caco2 (A, images a and e) and HT29B6 (B, images a and e). Immunostaining for tight junction proteins claudin-1, claudin-5, and occludin (A, images f-h, and B, images f-h) showed an augmented and more linear staining pattern following GDNF compared with control conditions (A, images a-d, and B, images a-d) .
No changes in staining could be observed after incubation with GDNF under mature barrier conditions in both Caco2 and HT29B6 (experiments shown are representative for n Ͼ 5; scale bar, 20 m). C and D: in Western blots, concentrations of junctional proteins E-cadherin, occludin, claudin-1, and claudin-5 were not altered after incubation with GDNF for 24 h in either immature or mature Caco2 and HT29B6 cells. ␤-Actin served as loading control (C). Vertical lines indicate noncontiguous lanes that were derived from the same gel (experiments shown in C are representative for n ϭ 5 experiments).
GDNF induced proliferation in a cAMP/PKA-dependent manner in vitro. Next we tested whether GDNF would affect epithelial wound healing and performed "scratch assays" in monolayers of Caco2 cells and documented wound closure in the time course of 72 h with and without application of GDNF. Immediately after the lesion, the wounded areas were measured. At this time point, there were no significant differences in the sizes of the wounded areas. After lesion of the cell monolayers the wound closure was documented after 24, 48, and 72 h by calculating the ratio of the wounded area in relation to the initial scratch (Fig. 5A) . In untreated controls, 33 Ϯ 3% of the scratch area was closed after 24 h. Incubation of GDNF resulted in a significantly enhanced epithelial wound closure that amounted to 45 Ϯ 3% after 24 h (Fig. 5B) . This was also observed in the following time points measured. In the scratched monolayers treated with GDNF, wound healing was completed after 72 h, whereas controls still displayed an area of 4 Ϯ 1% (Fig. 5B) , which in summary demonstrated that GDNF promotes epithelial wound healing.
To evaluate the potential effects of GDNF on cell proliferation, we analyzed the percentage of Ki-67-positive cells after application of GDNF compared with untreated controls. Immunostainings of immature Caco2 cells with Ki-67 and DAPI to visualize cell nuclei were performed (Fig. 6A ). Ki-67positive cells were quantified compared with the total number of cells as revealed by the number of cell nuclei. Incubation with GDNF for 24 h significantly increased the ratio of Ki-67positive cells to 24.4 Ϯ 3.6% compared with 11.3 Ϯ 1.7% in untreated controls, i.e., an increased rate of 214% of controls (Fig. 6, A and B) . In an attempt to resolve the potential role of cAMP-dependent signaling by GDNF, we applied the PKA inhibitor H-89 together with GDNF. This led to a significantly reduced number of Ki-67-positive cells, to 13.4 Ϯ 2.0% (Fig.  6B ), which showed that PKA inhibition blocked GDNF-induced proliferation. Additionally, we performed Ki-67 staining following application of F/R to augment cAMP levels, which resulted in a significant increase in Ki-67-positive cells of 35.9 Ϯ 6.8 (Fig. 6B) .
DISCUSSION
In the present study, we tested the effects of GDNF on intestinal epithelial barrier functions in vitro. Our data suggest that enterocytes represent a source for GDNF in the intestine in addition to glial cells in the submucosal and myenteric plexus. Furthermore, we found that GDNF in differentiated entero- Fig. 4 . cAMP signaling and p38 MAPK signaling were affected by GDNF. A: ELISA-based measurements of cAMP levels in immature Caco2 monolayers were performed under control conditions and after incubation with GDNF, which significantly augmented cAMP levels to 122 Ϯ 8% of controls (n ϭ 6, P Ͻ 0.05). B: PE of 4-kDa FITC dextran flux across immature monolayers were decreased after GDNF application and not altered after incubation with H-89 alone. GDNF ϩ H-89 blocked GDNFinduced barrier stabilization. PE was significantly increased following incubation with forskolin and rolipram (F/R); application of H-89 did not alter PE significantly (n ϭ 8 experiments). C: Western blotting showed a continuous decrease in p38 MAPK phosphorylation following incubation with GDNF for 6 and 24 h in immature Caco2, as indicated by reduced density of the phospho-p38 MAPK-specific band (pp38 MAPK). Total p38 MAPK remained unaltered (experiment shown is representative for n ϭ 5). D: quantification of the pp38 MAPK bands of all experiments following incubation of Caco2 cells with GDNF for 6 and 24 h is shown (n ϭ 5). E: PE of 4-kDa FITC dextran flux across immature Caco2 monolayers were significantly decreased following incubation with SB-202190, which was used to block p38 MAPK signaling and significantly increased after application of anisomycin. Anisomycin blocked GDNF-induced barrier stabilization (n ϭ 6 experiments). F: in HT29B6 cells, activation of p38 MAPK by anisomycin alone resulted in a significant increase in PE. Application of anisomycin with GDNF blocked GDNF-induced barrier stabilization (n ϭ 8 experiments). *P Ͻ 0.05 compared with controls. cytes exerted no additional barrier-stabilizing effects in a mature barrier. However, under immature barrier conditions, GDNF led to more linearized and augmented staining patterns of the tight junction proteins claudin-1, claudin-5, and occludin at the cell borders. These effects were paralleled by a stabilization of intestinal epithelial barrier functions, as revealed by a significant decrease in 4 kDa FITC-dextran flux and increased TER. In support of the hypothesis that GDNF augments maturation of epithelial barrier functions, we found that application of GDNF induced a faster wound closure in a woundhealing assay by increasing the proliferation rate of Caco2 cells, as shown by an enhanced number of Ki-67-positive cells. Interestingly, GDNF increased the concentration of cAMP only in immature Caco2 cells in an ELISA-based assay, which was also observed for inactivation of p38 MAPK by GDNF. Experiments mimicking the signaling of GDNF suggested that inhibition of p38MAPK predominately induced barrier maturation. This was supported by the fact that activation of p38 MAPK by anisomycin blocked the barrier-maturating effects of GDNF. Augmented cAMP levels increased the proliferation rate and thereby may have promoted epithelial wound healing (Fig. 7) .
Enterocytes may represent a source for GDNF in the intestine. Our data suggest that besides the enteric nervous system, enterocytes may represent a source for GDNF since enterocytes showed a positive immunostaining signal in tissue sections from the human intestine. However, as outlined above, the positive staining for GDNF may represent bound GDNF that had previously been secreted by the glial cells. Therefore, we performed in vitro studies where only Caco2 or HT29B6 cells were present to test whether these cells were positive for GDNF, which was the case according to Western blot analysis. Furthermore, we found GDNF in the supernatant of serumstarved Caco2 cells, which in summary shows that intestinal epithelial cell synthesize and secrete GDNF. In general, the observation that epithelial cells can produce GDNF was made previously in oral squamous cells (7) . The fact that enterocytes provide an additional source for GDNF may point to a novel regulatory mechanism in which mucosal healing is mediated by enterocyte-mediated GDNF secretion in terms of an autocrine or paracrine loop. The physiological relevance of this hypothesis remains to be investigated in more detail.
Caco2 and HT29B6 cells represent a suitable model for investigations of the intestinal epithelial barrier in vitro. The mammalian intestinal epithelium undergoes continuous and rapid renewal (21) . Hence, for a better understanding of intestinal epithelial barrier function, a suitable in vitro model is essential. For our investigations, we used Caco2 and HT29B6 cells that were originally extracted from colon carcinomas (11, 13) . Since then, Caco2 and HT29B6 cells have been used intensively as a model for intestinal epithelial barrier function since they differentiate into polarized cells, which closely resemble enterocytes in morphology and function dependent on cell culture conditions (27, 29) . Furthermore, it has been reported that premature Caco2 and HT29B6 cells share many aspects of undifferentiated enterocytes that can be found in the mammalian intestinal crypt (24) . For example, scattered tight junction morphology in immature cells closely represents morphology of tight junctions in crypts, as revealed by freeze fracture (1, 12, 33) . In support of that, it was assumed from measurements of different tracers that intestinal villi with a mature barrier have a huge number of narrow tight junctions, whereas junctions in the crypts are more leaky (15) . All of these observations underline the need to investigate the cells at the different stages of differentiation. Therefore, as also shown in our previous investigations (29) , we used Caco2 cells with regularly distributed junctional proteins and a stable P E as model for a mature intestinal epithelial barrier, whereas Caco2 cells at the point of confluence represent a model for immature barrier properties that is typically seen in crypts.
GDNF-induced barrier maturation and cell proliferation in vitro. In general, it was shown previously that intestinal epithelial cells can be affected directly and indirectly by GDNF (25, 36, 40, 44) . Indirect effects of GDNF were thought to be mediated mainly by affecting the cytokine response in inflammation (25) . According to this, the barrier-protective effects of GDNF in a murine in vivo model of bowel inflammation can at least in part be explained by these observations (45) . In our in vitro model, chronic inflammation of the intestine was mimicked by incubation with "cytomix" (6) , which led to a significant increase in epithelial permeability. Application of GDNF, however, did not change permeability changes that were induced by cytomix. Similarly, GDNF alone did not alter barrier properties in mature Caco2 monolayers. Therefore, when considering these findings together with the in vivo observations, it first appeared that indirect effects of GDNF rather than direct effects on intestinal epithelium may have played a dominant role for the previously reported protection of intestinal epithelial barrier protection by GDNF. Following this argumentation, the main effect of GDNF on the intestinal epithelial barrier in the in vivo models would be caused by preventing cytokine response in inflammation (25) .
However, according to our present data, GDNF also induces direct effects on Caco2 and HT29B6 cells. We observed that GDNF when applied on immature Caco2 and HT29B6 cells led to a stabilization of epithelial barrier functions, as revealed by measurements of 4-kDa FITC-dextran flux and by TER measurements. These changes were paralleled by an increase and by linearization of claudin-1 and claudin-5 as well as occludin staining, indicating that GDNF accelerates barrier maturation. A comparable observation was made previously in endothelial cells of the blood-brain barrier for claudin-5 (34) . In support of that, direct effects of GDNF in enterocytes were evident in a study where GDNF was shown to prevent apoptosis (36, 45) . Also, the latter study clearly demonstrated the presence of the GDNF receptors in enterocytes and different enterocyte-like cell lines (36) . This was also the case in both cell lines used in the present study. In addition to antiapoptotic effects seen in previous studies, we found that epithelial wound healing was improved after GDNF application by increasing proliferation of cells. This was substantiated by experiments using Ki-67 staining, which was significantly increased following GDNF application compared with untreated controls. These data support a previous finding in which coculture of enteric glial cells with HT29 cells improved migration and proliferation due to an altered transcriptome (39) .
Effects of GDNF on barrier maturation and proliferation were mediated by cAMP/PKA and p38 MAPK signaling. GDNF mediates its effects via a multi-component receptor complex consisting of GDNF receptor ␣1-4 as a ligandbinding component and receptor tyrosine kinase Ret as a signaling component (37) . Activation of this receptor complex can lead to modification of various signaling events, including p38 MAPK, ERK, protein kinase B (Akt), and PKA activation. The GDNF-susceptible receptors were present in our intestinal epithelial cell lines, as shown by Western blotting. Previously, it was demonstrated in neurons that GDNF increases cAMP levels and thereby activates PKA signaling, which in turn activates ERK signaling, leading to neurite outgrowth (42) . Because localized augmentation of cAMP levels contributes to tight and adherens junction stabilization in endothelial cells (31) , we focused on a first step of cAMP-dependent mechanisms on epithelial barrier maturation by GDNF. Indeed, we found that GDNF augmented cAMP levels in Caco2 cells with immature barrier properties. Inhibition of the cAMP/PKA signaling pathway had no effect on basal permeability, and PKA inhibition by H-89 blocked GDNF-induced barrier maturation. However, increased cAMP levels by F/R had adverse effects on barrier maturation and even led to increased epithelial permeability. This points to a role of cAMP/PKA signaling by GDNF that differs from barrier maturation alone. This assumption is supported by the observation that increased cAMP levels led to a reduction of E-cadherin integrity (3) . Therefore, to further resolve the role of cAMP/PKA signaling by GDNF, we performed wound-healing assays in epithelial monolayers. Therein, we observed increased proliferation following GDNF and F/R and accordingly inhibition of PKA using H-89-blocked GDNF-induced proliferation. Therefore, it can be assumed from these data that cAMP/PKA signaling predominately contributes to epithelial wound healing. These data are not consistent with a previous study in which increased cAMP levels led to a decreased migration in epithelial cells (46) , which may be explained by the fact that other epithelial cell lines were used for this study. In summary, we suggest that reduced E-cadherin integrity by cAMP/PKA signaling abrogates contact inhibition of epithelial cells, transferring them into a proliferative state that may contribute to epithelial wound healing.
In a second step, we investigated the effects of GDNF on p38 MAPK signaling. Interestingly, we found a significant dephosphorylation of p38 MAPK by GDNF. Although little is known about the role of p38 MAPK signaling in the regulation of intestinal barrier properties, phosphorylation of p38 MAPK was shown to activate the myosin-light chain kinase (9) . This leads to contraction of the actin-myosin ring to which the junctional complex is tethered via adaptor proteins and thereby induces destabilization of the epithelial barrier (38) . In line with these observations, the application of SB-202190 on immature Caco2 cells to mimic the inhibition of p38 MAPK signaling led to epithelial barrier stabilization. Vice versa, activation of p38 MAPK signaling using anisomycin led to increased permeability and blocked GDNF-induced barrier stabilization in both cell lines. Therefore, it can be concluded that GDNF-induced inhibition of p38 MAPK signaling contributes to barrier maturation. The predominant role of p38 MAPK signaling in the context of intestinal epithelial barrier regulation is also supported by our previous study in which TNF␣-induced loss of intestinal barrier integrity was mediated by activation of p38 MAPK (34) .
In summary, this study extends the current knowledge on the effects of GDNF on intestinal epithelial cells showing that GDNF promotes epithelial wound healing and barrier maturation by cAMP/PKA and p38 MAPK-dependent mechanisms. This may contribute to a better understanding of how the enteric nervous system interacts with intestinal epithelium in health and disease. Moreover, our present data show that enterocytes secrete GDNF, which may point to a novel autocrine or paracrine regulatory mechanism to mediate enterocyte differentiation at the mucosal level.
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